732:
132:
66:
25:
234:
935:
This program supports a combination of mentors and MS postdoctoral training institutions to recruit and train MS rehabilitation fellows. Mentors are required to be experienced MS researchers who have an established and active participation in their field. Interested parties must submit an application
976:
High-risk pilot research programs focus on cutting-edge ideas and methods that have not been tested and may contribute to MS medical research. The Pilot
Research Grants provide one year of research funding to pilot programs in order to develop results which can be used to apply for long term funding
887:
Fast
Forward is a commercial research funding entity under the NMSS which provides funding for drug development and MS research being conducted through commercial entities such as EMD Pharmaceuticals, the University of Cambridge, the University of Edinburgh, and others. Researchers interested in the
875:
The NMSS offers funding to research centers with the intent to promote interaction among researchers. The
Collaborative MS Research Center Awards program is intended to create collaboration between MS researchers, including independent investigators, and clinical research organizations. In addition,
866:
The Career
Transition Fellowship program sponsors postdoctoral training and research funding for scientists who demonstrate a dedication to MS research. Awards are in amounts up to $ 550,000 for a total of five years of training and research. The training period covers two years and research funding
908:
was a researcher in the field of neuroscience who had a dedication to MS research. He was the
Director of Research at NMSS from 1966 to 1977. The scholarship in his name is offered to provide salary and research funding for a period of five years to researchers who are beginning their careers in MS
795:
founded in 1946. It is an organization dedicated to supporting individuals affected by multiple sclerosis (MS) and funding research to find a cure for the disease. They provide resources, support services, advocacy efforts, and educational programs to improve the lives of people with MS and their
926:
The
International Progressive MS Alliance was founded in 2012 as the International Progressive MS Collaborative. The MS Alliance membership is composed of MS organizations from around the world. The Alliance provides two different funding awards, including the Challenge Award and Collaborative
967:
and NMSS have partnered to develop this grant program. The program focuses on providing grant funding to MS researchers. In 2016, the
American Academy of Neuroscience Clinician Scientist Development Program awarded $ 3 million to research and training programs with a focus on neuroscience.
846:
Throughout two two-day meetings in 2014–2015, the NMSS developed the
Wellness Research Working Group and wellness research priorities. The Research Wellness Group provides information regarding self-directed approaches for disease management to people diagnosed with multiple sclerosis.
917:
The Health Care
Delivery and Policy Research (HCDPR) program funds investigators who are conducting research projects which address NMSS organization's priorities. These priorities are listed by the NMSS as funding, quality, outcomes, and costs for care related to MS.
896:
This award was named after a member of the Board of
Directors of the NMSS. Its purpose was to provide funding for training of MS researchers who needed additional education regarding the disease. As of 2017, this award was on hold and not accepting applications.
812:. a lawyer seeking a cure for her brother, Bernard, who suffered from multiple sclerosis. Recognizing the absence of any existing foundation or organization aiding individuals with (MS), Ms. Lawry established NMSS.
843:
to find out whether they are effective in treating MS. In 2012, the Society invested $ 44 million in more than 350 new and ongoing projects. As of 2016, NMSS has raised $ 974 million for research.
1182:
1706:
853:
consist of several types of contributions to researchers in early to late stages of their careers. The following is a list of awards distributed by NMSS to researchers in 2017.
248:
1904:
460:
1797:
1304:
1085:
Motl, Robert W; Mowry, Ellen M; Ehde, Dawn M; LaRocca, Nicholas G; Smith, Kathy E; Costello, Kathleen; Shinto, Lynne; Ng, Alexander V; Sullivan, Amy B (2017-01-12).
1884:
76:
1363:
1061:
1142:
1507:
149:
38:
819:, the organization funds research, advocates for social and political change, offers educational resources, and sponsors services that help people with
1696:
196:
1792:
839:
The NMSS supports and funds research activities in early research, translational research that develops laboratory results into treatments, and
168:
948:
1894:
1190:
770:
175:
1356:
597:
252:
91:
1889:
927:
Network Award grants. Both grants provide funding over multiple years to researchers and institutions in the international community.
1899:
1744:
182:
1848:
1381:
450:
44:
1228:
1087:"Wellness and multiple sclerosis: The National MS Society establishes a Wellness Research Working Group and research priorities"
164:
1853:
1729:
1676:
1349:
1863:
1668:
1042:
1828:
1754:
1714:
561:
876:
the program reaches out to professionals working in other fields of research to recruit them into MS research projects.
940:
637:
741:
292:
274:
215:
113:
52:
1858:
1787:
1734:
1724:
1681:
1535:
1502:
1482:
763:
627:
470:
367:
1823:
1455:
256:
189:
95:
1739:
1651:
632:
489:
153:
964:
944:
445:
420:
83:
1818:
1782:
1477:
879:
MS Research Center Awards are obtained through an application process through the NMSS MS Grants web page.
566:
1170:
905:
756:
581:
576:
333:
1017:
1341:
493:
440:
338:
1719:
1604:
1394:
586:
380:
362:
465:
1439:
714:
142:
243:
may contain an excessive amount of intricate detail that may interest only a particular audience
1373:
999:
792:
704:
1073:
888:
program are able to apply for funding through the Commercial Funding Opportunities web page.
455:
1762:
1686:
1419:
507:
415:
343:
808:
as the Association for Advancement of Research on Multiple Sclerosis on March 11, 1946 by
8:
1590:
1512:
736:
390:
1252:
1691:
1575:
1570:
1565:
1555:
1119:
1086:
1018:"National Multiple Sclerosis Society on the Forbes The 100 Largest U.S. Charities List"
952:
820:
697:
323:
1767:
1550:
1460:
1124:
1106:
828:
542:
502:
385:
1229:"Mentor-Based Postdoctoral Fellowship in Rehabilitation Research | Research Funding"
1492:
1114:
1098:
673:
668:
537:
410:
1802:
1772:
512:
1777:
1467:
1429:
1305:"Announcing the 2016 American Academy of Neurology Research Program Recipients"
840:
709:
683:
571:
87:
1878:
1625:
1110:
1102:
816:
805:
527:
375:
827:
ranked the organization 63rd among the 100 largest U.S. charities. In 2017,
255:
any relevant information, and removing excessive detail that may be against
1585:
1128:
809:
642:
591:
517:
1600:
1595:
1540:
678:
1371:
1204:
1644:
1580:
1560:
1545:
1519:
1404:
660:
532:
308:
1171:
https://researchfunding.duke.edu/daniel-haughton-senior-faculty-awards
867:
covers three additional years for research in a new faculty position.
831:
awarded the organization three out of four stars for its performance.
1620:
1615:
1424:
1409:
1143:"List of Current Research Projects Funded by the National MS Society"
522:
1062:
List of Current Research Projects Funded by the National MS Society.
909:
research. The program is most often supported through universities.
131:
1610:
1399:
1334:
1414:
647:
328:
1389:
824:
1277:"Home – Office of Sponsored Projects – The University of Utah"
912:
804:
The National Multiple Sclerosis Society (NMSS) was founded in
1434:
930:
882:
1798:
Megalencephalic leukoencephalopathy with subcortical cysts
1183:"International Progressive MS Alliance | Challenge Awards"
870:
900:
958:
921:
1276:
891:
1043:"When Donating to MS Causes, Where Does the Money Go?"
856:
1508:
Lesional demyelinations of the central nervous system
1084:
94:, and by adding encyclopedic content written from a
1905:
Disability organizations based in the United States
156:. Unsourced material may be challenged and removed.
1697:Chronic inflammatory demyelinating polyneuropathy
1876:
1885:Non-profit organizations based in New York City
1793:Leukoencephalopathy with vanishing white matter
861:
949:University of Colorado Anschutz Medical Campus
1357:
764:
913:Health Care Delivery & Policy Contracts
53:Learn how and when to remove these messages
1364:
1350:
936:for the program through the NMSS website.
771:
757:
1745:Experimental autoimmune encephalomyelitis
1205:"International Progressive MS Alliance |"
1118:
293:Learn how and when to remove this message
275:Learn how and when to remove this message
216:Learn how and when to remove this message
114:Learn how and when to remove this message
1849:List of multiple sclerosis organizations
971:
939:Participants in the program include the
931:Mentor-based Postdoctoral Rehabilitation
883:Fast Forward commercial/drug development
955:, and additional related institutions.
871:Collaborative MS Research Center Awards
1877:
1854:List of people with multiple sclerosis
1730:Neuromyelitis optica spectrum disorder
1677:Neuromyelitis optica spectrum disorder
1040:
901:Harry Weaver Neuroscience Scholarships
368:Individualized Education Program (IEP)
75:contains content that is written like
1345:
1302:
1298:
1296:
1253:"National Multiple Sclerosis Society"
959:Clinician Scientist Development Award
922:International Progressive MS Alliance
638:Disabled Peoples' International (DPI)
165:"National Multiple Sclerosis Society"
1895:1946 establishments in New York City
1829:Mitochondrial DNA depletion syndrome
1715:Acute disseminated encephalomyelitis
994:
992:
990:
892:Daniel Haughton Senior Faculty Award
562:Social Security Disability Insurance
227:
154:adding citations to reliable sources
125:
59:
18:
1150:National Multiple Sclerosis Society
857:Research funding and grant programs
785:National Multiple Sclerosis Society
13:
1293:
941:Duke University School of Medicine
14:
1916:
1890:Organizations established in 1946
1326:
987:
34:This article has multiple issues.
1900:Multiple sclerosis organizations
1859:Multiple sclerosis drug pipeline
1735:Diffuse myelinoclastic sclerosis
1725:Marburg acute multiple sclerosis
1682:Diffuse myelinoclastic sclerosis
1536:Management of multiple sclerosis
1503:Radiologically isolated syndrome
1483:Expanded Disability Status Scale
1303:Neurology, American Academy of.
731:
730:
628:National Telecommuting Institute
232:
130:
64:
23:
1456:Diagnosis of multiple sclerosis
1269:
1245:
1221:
1197:
141:needs additional citations for
42:or discuss these issues on the
16:American nonprofit organization
1740:Tumefactive multiple sclerosis
1652:Research in multiple sclerosis
1372:Demyelinating diseases of the
1175:
1164:
1135:
1078:
1067:
1055:
1034:
1010:
633:Society for Disability Studies
490:Unlicensed assistive personnel
1:
1209:www.progressivemsalliance.org
1187:www.progressivemsalliance.org
1041:Tobias, Ed (September 2017).
980:
965:American Academy of Neurology
945:Weizmann Institute of Science
823:and their families. In 2016,
1819:Central pontine myelinolysis
1788:Pelizaeus–Merzbacher disease
1783:Metachromatic leukodystrophy
1478:Clinically isolated syndrome
1449:Investigations and diagnosis
862:Career Transition Fellowship
567:Supplemental Security Income
329:Ableism / Disablism
257:Knowledge's inclusion policy
7:
1824:Marchiafava–Bignami disease
834:
815:With chapters spanning the
582:Disabled students allowance
577:Disability Living Allowance
10:
1921:
1091:Multiple Sclerosis Journal
799:
441:Disability rights movement
1841:
1811:
1753:
1720:Balo concentric sclerosis
1705:
1667:
1660:
1634:
1528:
1448:
1380:
587:Disabled Persons Railcard
1233:researchfunding.duke.edu
1103:10.1177/1352458516687404
600:the Severely Handicapped
556:Socioeconomic assistance
466:Sexuality and disability
715:Disability in the media
1661:Demyelinating diseases
1374:central nervous system
793:nonprofit organization
705:Disability in the arts
528:Physical accessibility
972:Pilot Research Grants
456:People-first language
434:Societal implications
96:neutral point of view
1763:Adrenoleukodystrophy
1687:MOG antibody disease
1489:Serological and CSF
1440:Uhthoff's phenomenon
523:Orthotics and braces
508:Assistive technology
150:improve this article
1591:Monomethyl fumarate
1004:National MS Society
484:Personal assistance
391:Learning disability
88:promotional content
1692:Multiple sclerosis
1576:Interferon beta-1b
1571:Interferon beta-1a
1566:Glatiramer acetate
1556:Diroximel fumarate
1529:Approved treatment
1382:Signs and symptoms
1309:www.prnewswire.com
1257:www.weizmann.ac.il
953:University of Utah
821:multiple sclerosis
598:Assured Income for
90:and inappropriate
1872:
1871:
1837:
1836:
1768:Alexander disease
1551:Dimethyl fumarate
1493:Oligoclonal bands
1461:McDonald criteria
829:Charity Navigator
791:) is an American
781:
780:
543:Web accessibility
503:Accessible toilet
386:Special education
324:Disability theory
317:Theory and models
303:
302:
295:
285:
284:
277:
226:
225:
218:
200:
124:
123:
116:
57:
1912:
1665:
1664:
1635:Other treatments
1513:Dawson's fingers
1366:
1359:
1352:
1343:
1342:
1338:
1337:
1335:Official website
1320:
1319:
1317:
1316:
1300:
1291:
1290:
1288:
1287:
1273:
1267:
1266:
1264:
1263:
1249:
1243:
1242:
1240:
1239:
1225:
1219:
1218:
1216:
1215:
1201:
1195:
1194:
1189:. Archived from
1179:
1173:
1168:
1162:
1161:
1159:
1157:
1147:
1139:
1133:
1132:
1122:
1082:
1076:
1074:Research We Fund
1071:
1065:
1059:
1053:
1052:
1050:
1049:
1038:
1032:
1031:
1029:
1028:
1014:
1008:
1007:
996:
851:Research rewards
773:
766:
759:
734:
733:
674:Paralympic Games
669:Special Olympics
538:Universal design
461:Pejorative terms
305:
304:
298:
291:
280:
273:
269:
266:
260:
236:
235:
228:
221:
214:
210:
207:
201:
199:
158:
134:
126:
119:
112:
108:
105:
99:
77:an advertisement
68:
67:
60:
49:
27:
26:
19:
1920:
1919:
1915:
1914:
1913:
1911:
1910:
1909:
1875:
1874:
1873:
1868:
1864:Pathophysiology
1833:
1807:
1803:CAMFAK syndrome
1773:Canavan disease
1749:
1701:
1656:
1630:
1524:
1444:
1376:
1370:
1333:
1332:
1329:
1324:
1323:
1314:
1312:
1311:(Press release)
1301:
1294:
1285:
1283:
1275:
1274:
1270:
1261:
1259:
1251:
1250:
1246:
1237:
1235:
1227:
1226:
1222:
1213:
1211:
1203:
1202:
1198:
1181:
1180:
1176:
1169:
1165:
1155:
1153:
1145:
1141:
1140:
1136:
1083:
1079:
1072:
1068:
1060:
1056:
1047:
1045:
1039:
1035:
1026:
1024:
1016:
1015:
1011:
998:
997:
988:
983:
974:
961:
933:
924:
915:
903:
894:
885:
873:
864:
859:
841:clinical trials
837:
802:
777:
746:
720:
719:
700:
690:
689:
688:
663:
653:
652:
623:
622:
606:
605:
602:
599:
557:
549:
548:
547:
513:Assisted living
485:
477:
476:
475:
435:
427:
426:
425:
405:
397:
396:
395:
358:
350:
349:
348:
318:
299:
288:
287:
286:
281:
270:
264:
261:
247:Please help by
246:
237:
233:
222:
211:
205:
202:
159:
157:
147:
135:
120:
109:
103:
100:
81:
69:
65:
28:
24:
17:
12:
11:
5:
1918:
1908:
1907:
1902:
1897:
1892:
1887:
1870:
1869:
1867:
1866:
1861:
1856:
1851:
1845:
1843:
1839:
1838:
1835:
1834:
1832:
1831:
1826:
1821:
1815:
1813:
1809:
1808:
1806:
1805:
1800:
1795:
1790:
1785:
1780:
1778:Krabbe disease
1775:
1770:
1765:
1759:
1757:
1751:
1750:
1748:
1747:
1742:
1737:
1732:
1727:
1722:
1717:
1711:
1709:
1703:
1702:
1700:
1699:
1694:
1689:
1684:
1679:
1673:
1671:
1662:
1658:
1657:
1655:
1654:
1649:
1648:
1647:
1638:
1636:
1632:
1631:
1629:
1628:
1623:
1618:
1613:
1608:
1605:+hyaluronidase
1598:
1593:
1588:
1583:
1578:
1573:
1568:
1563:
1558:
1553:
1548:
1543:
1538:
1532:
1530:
1526:
1525:
1523:
1522:
1517:
1516:
1515:
1510:
1505:
1497:
1496:
1495:
1487:
1486:
1485:
1480:
1471:
1470:
1468:Poser criteria
1465:
1464:
1463:
1452:
1450:
1446:
1445:
1443:
1442:
1437:
1432:
1430:Optic neuritis
1427:
1422:
1417:
1412:
1407:
1402:
1397:
1392:
1386:
1384:
1378:
1377:
1369:
1368:
1361:
1354:
1346:
1340:
1339:
1328:
1327:External links
1325:
1322:
1321:
1292:
1268:
1244:
1220:
1196:
1193:on 2015-09-18.
1174:
1163:
1152:. January 2017
1134:
1097:(3): 262–267.
1077:
1066:
1054:
1033:
1009:
985:
984:
982:
979:
973:
970:
960:
957:
932:
929:
923:
920:
914:
911:
902:
899:
893:
890:
884:
881:
872:
869:
863:
860:
858:
855:
836:
833:
801:
798:
779:
778:
776:
775:
768:
761:
753:
750:
749:
748:
747:
745:
744:
739:
727:
722:
721:
718:
717:
712:
710:Disability art
707:
701:
696:
695:
692:
691:
687:
686:
684:Invictus Games
681:
676:
671:
665:
664:
659:
658:
655:
654:
651:
650:
645:
640:
635:
630:
624:
621:
620:
617:
613:
612:
611:
608:
607:
604:
603:
596:
594:
589:
584:
579:
574:
572:Ticket to Work
569:
564:
558:
555:
554:
551:
550:
546:
545:
540:
535:
530:
525:
520:
515:
510:
505:
499:
498:
497:
486:
483:
482:
479:
478:
474:
473:
471:Women's health
468:
463:
458:
453:
448:
443:
437:
436:
433:
432:
429:
428:
424:
423:
418:
413:
407:
406:
403:
402:
399:
398:
394:
393:
388:
383:
381:Special school
378:
372:
371:
370:
365:
359:
356:
355:
352:
351:
347:
346:
341:
336:
331:
326:
320:
319:
316:
315:
312:
311:
301:
300:
283:
282:
240:
238:
231:
224:
223:
206:September 2008
138:
136:
129:
122:
121:
92:external links
72:
70:
63:
58:
32:
31:
29:
22:
15:
9:
6:
4:
3:
2:
1917:
1906:
1903:
1901:
1898:
1896:
1893:
1891:
1888:
1886:
1883:
1882:
1880:
1865:
1862:
1860:
1857:
1855:
1852:
1850:
1847:
1846:
1844:
1840:
1830:
1827:
1825:
1822:
1820:
1817:
1816:
1814:
1810:
1804:
1801:
1799:
1796:
1794:
1791:
1789:
1786:
1784:
1781:
1779:
1776:
1774:
1771:
1769:
1766:
1764:
1761:
1760:
1758:
1756:
1752:
1746:
1743:
1741:
1738:
1736:
1733:
1731:
1728:
1726:
1723:
1721:
1718:
1716:
1713:
1712:
1710:
1708:
1704:
1698:
1695:
1693:
1690:
1688:
1685:
1683:
1680:
1678:
1675:
1674:
1672:
1670:
1666:
1663:
1659:
1653:
1650:
1646:
1643:
1642:
1640:
1639:
1637:
1633:
1627:
1626:Teriflunomide
1624:
1622:
1619:
1617:
1614:
1612:
1609:
1606:
1602:
1599:
1597:
1594:
1592:
1589:
1587:
1584:
1582:
1579:
1577:
1574:
1572:
1569:
1567:
1564:
1562:
1559:
1557:
1554:
1552:
1549:
1547:
1544:
1542:
1539:
1537:
1534:
1533:
1531:
1527:
1521:
1518:
1514:
1511:
1509:
1506:
1504:
1501:
1500:
1499:Radiological
1498:
1494:
1491:
1490:
1488:
1484:
1481:
1479:
1476:
1475:
1473:
1472:
1469:
1466:
1462:
1459:
1458:
1457:
1454:
1453:
1451:
1447:
1441:
1438:
1436:
1433:
1431:
1428:
1426:
1423:
1421:
1418:
1416:
1413:
1411:
1408:
1406:
1403:
1401:
1398:
1396:
1393:
1391:
1388:
1387:
1385:
1383:
1379:
1375:
1367:
1362:
1360:
1355:
1353:
1348:
1347:
1344:
1336:
1331:
1330:
1310:
1306:
1299:
1297:
1282:
1278:
1272:
1258:
1254:
1248:
1234:
1230:
1224:
1210:
1206:
1200:
1192:
1188:
1184:
1178:
1172:
1167:
1151:
1144:
1138:
1130:
1126:
1121:
1116:
1112:
1108:
1104:
1100:
1096:
1092:
1088:
1081:
1075:
1070:
1063:
1058:
1044:
1037:
1023:
1019:
1013:
1005:
1001:
995:
993:
991:
986:
978:
969:
966:
956:
954:
950:
946:
942:
937:
928:
919:
910:
907:
898:
889:
880:
877:
868:
854:
852:
848:
844:
842:
832:
830:
826:
822:
818:
817:United States
813:
811:
807:
806:New York City
797:
794:
790:
786:
774:
769:
767:
762:
760:
755:
754:
752:
751:
743:
740:
738:
729:
728:
726:
725:
724:
723:
716:
713:
711:
708:
706:
703:
702:
699:
694:
693:
685:
682:
680:
677:
675:
672:
670:
667:
666:
662:
657:
656:
649:
646:
644:
641:
639:
636:
634:
631:
629:
626:
625:
619:Organizations
618:
615:
614:
610:
609:
601:
595:
593:
590:
588:
585:
583:
580:
578:
575:
573:
570:
568:
565:
563:
560:
559:
553:
552:
544:
541:
539:
536:
534:
531:
529:
526:
524:
521:
519:
516:
514:
511:
509:
506:
504:
501:
500:
495:
491:
488:
487:
481:
480:
472:
469:
467:
464:
462:
459:
457:
454:
452:
451:Normalization
449:
447:
444:
442:
439:
438:
431:
430:
422:
419:
417:
414:
412:
409:
408:
401:
400:
392:
389:
387:
384:
382:
379:
377:
376:Special needs
374:
373:
369:
366:
364:
363:Mainstreaming
361:
360:
354:
353:
345:
342:
340:
337:
335:
334:Medical model
332:
330:
327:
325:
322:
321:
314:
313:
310:
307:
306:
297:
294:
279:
276:
268:
258:
254:
250:
244:
241:This article
239:
230:
229:
220:
217:
209:
198:
195:
191:
188:
184:
181:
177:
174:
170:
167: –
166:
162:
161:Find sources:
155:
151:
145:
144:
139:This article
137:
133:
128:
127:
118:
115:
107:
97:
93:
89:
85:
79:
78:
73:This article
71:
62:
61:
56:
54:
47:
46:
41:
40:
35:
30:
21:
20:
1707:Inflammatory
1586:Mitoxantrone
1420:Incontinence
1313:. Retrieved
1308:
1284:. Retrieved
1281:osp.utah.edu
1280:
1271:
1260:. Retrieved
1256:
1247:
1236:. Retrieved
1232:
1223:
1212:. Retrieved
1208:
1199:
1191:the original
1186:
1177:
1166:
1154:. Retrieved
1149:
1137:
1094:
1090:
1080:
1069:
1057:
1046:. Retrieved
1036:
1025:. Retrieved
1021:
1012:
1003:
975:
962:
938:
934:
925:
916:
906:Harry Weaver
904:
895:
886:
878:
874:
865:
850:
849:
845:
838:
814:
810:Sylvia Lawry
803:
788:
784:
782:
643:Visitability
592:Freedom Pass
518:Mobility aid
416:Occupational
344:Other models
339:Social model
289:
271:
262:
249:spinning off
242:
212:
203:
193:
186:
179:
172:
160:
148:Please help
143:verification
140:
110:
104:January 2014
101:
86:by removing
82:Please help
74:
50:
43:
37:
36:Please help
33:
1601:Ocrelizumab
1596:Natalizumab
1541:Alemtuzumab
1000:"Our Story"
679:Deaflympics
533:Prosthetics
1879:Categories
1755:Hereditary
1669:Autoimmune
1645:Daclizumab
1581:Laquinimod
1561:Fingolimod
1546:Cladribine
1520:Frexalimab
1405:Dysarthria
1395:Depression
1315:2017-05-13
1286:2017-05-13
1262:2017-05-13
1238:2017-05-13
1214:2017-05-13
1048:2021-04-06
1027:2017-05-12
981:References
977:programs.
796:families.
737:Disability
661:Parasports
309:Disability
253:relocating
176:newspapers
84:improve it
39:improve it
1621:Siponimod
1616:Ponesimod
1474:Clinical
1425:Nystagmus
1410:Dysphagia
1111:1352-4585
1064:May 2015
446:Inclusion
357:Education
265:June 2024
45:talk page
1611:Ozanimod
1400:Diplopia
1129:28080254
835:Research
411:Physical
1641:Former
1415:Fatigue
1156:May 12,
1120:5494005
800:History
698:Culture
648:WeThe15
492: (
404:Therapy
190:scholar
1390:Ataxia
1127:
1117:
1109:
1022:Forbes
943:, the
825:Forbes
735:
616:Groups
421:Speech
192:
185:
178:
171:
163:
1842:Other
1812:Other
1146:(PDF)
742:Lists
197:JSTOR
183:books
1435:Pain
1158:2017
1125:PMID
1107:ISSN
963:The
789:NMSS
783:The
494:ADLs
169:news
1115:PMC
1099:doi
251:or
152:by
1881::
1307:.
1295:^
1279:.
1255:.
1231:.
1207:.
1185:.
1148:.
1123:.
1113:.
1105:.
1095:24
1093:.
1089:.
1020:.
1002:.
989:^
951:,
947:,
48:.
1607:)
1603:(
1365:e
1358:t
1351:v
1318:.
1289:.
1265:.
1241:.
1217:.
1160:.
1131:.
1101::
1051:.
1030:.
1006:.
787:(
772:e
765:t
758:v
496:)
296:)
290:(
278:)
272:(
267:)
263:(
259:.
245:.
219:)
213:(
208:)
204:(
194:·
187:·
180:·
173:·
146:.
117:)
111:(
106:)
102:(
98:.
80:.
55:)
51:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
